Events

In person events

Clinical Trial Supply East Coast 2023

King of Prussia, PA, USA

11 - 12 Oct 2023

Event details

Czech-Made EU GMP cannabis-derived APIs

London, UK / New York, USA

17 October 2023

Event details

Clinical Trial Supply Nordics 2023

Kastrup, Denmark

24 - 25 October 2023

Event details

Outsourcing in Clinical Trials New England 2023

Boston, USA

1 - 2 Nov 2023

Event details

Outsourcing in Clinical Trials DACH 2023

Regensdorf, Switzerland

21 - 22 Nov 2023

Event details

Clinical Operations In Oncology Trials Europe 2023

Munich, Germany

28 - 29 Nov 2023

Event details

Outsourcing in Clinical Trials East Asia 2023

Seoul, South Korea

5 - 6 Dec 2023

Event details

Outsourcing in Clinical Trials: Medical Devices Europe 2024

Munich, Germany

30 - 31 Jan 2024

Event details

Outsourcing in Clinical Trials West Coast 2024

Burlingame, USA

6 - 7 Feb 2024

Event details

Outsourcing in Clinical Trials & Clinical Trial Supply Israel 2024

Tel-Aviv, Israel

26 - 27 Feb 2024

Event details

Temperature Controlled Logistics in Biopharmaceuticals Europe 2024

Barcelona, Spain

6 - 7 Mar 2024

Event details

Clinical Trial Supply Europe 2024

Barcelona, Spain

6 - 7 Mar 2024

Event details

Digital and hybrid events

AI in Pharma

Online

Event details

Other media partner events

PHARMAP

Amsterdam, the Netherlands

Event details

Go to article: Home | How pharma wants to break the efficacy ceiling in IBDGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: UrsatecGo to article: SHL Medical Company InsightGo to article: SHL MedicalGo to article: ControlantGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Owen Mumford Company InsightGo to article: Owen MumfordGo to article:  Sensified.ioGo to article: In DepthGo to article: How pharma wants to break the efficacy ceiling in IBDGo to article: Subcutaneous drugs grant a new lease on life to checkpoint inhibitorsGo to article: Hope for the UK clinical trial landscape but it requires a lot of work Go to article: Novo Nordisk’s Wegovy to start being supplied by NHS in EnglandGo to article: Minimal impact expected for first ten drugs released for Medicare price negotiationGo to article: Q&A: Human touch remains critical for the patient experience in trialsGo to article: Zenatek Company InsightGo to article: BEA TechnologiesGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue